Every year, May is Lupus Awareness Month across Kentucky and the rest of the country. Despite the severity of the disease, recent polling shows that nearly two-thirds of Americans are not familiar with the disease. This is unusual given 5 million people have lupus worldwide.

One major problem that stems from the lack of understanding of the disease is misdiagnosis. Early diagnosis is especially important because it can significantly improve the treatment of the disease. While there is no cure for lupus, there are many treatments that can limit symptoms and organ damage. The earlier the disease is diagnosed, the better the treatment options are.

To assist in early diagnosis, the lupus awareness group Exagen is making strides in technology that can detect the disease. In 2012, Exagen developed AVISE CTD, a unique early diagnostic test. AVISE incorporates cell-bound complement activation products, also known as CB-CAPs technology. The test is designed to diagnose systemic lupus erythematosus, which is the most common type of lupus. To mark lupus awareness month, Exagen has delivered 225,000 AVISE tests to over 1,500 medical facilities since the test launched in 2012. This is excellent news for lupus patients given that the AVISE test has been confirmed to be more accurate than standard bloodwork.

Misdiagnosis and the failure to diagnose are very common types of medical malpractice. They can lead to unnecessary surgery and improper medication prescriptions. An individual who is injured by unnecessary surgery or improper prescriptions may have a claim for damages. These damages can include medical bills, lost wages and pain and suffering. An attorney with experience in medical malpractice law can help someone by filing a lawsuit against the responsible doctor or negotiating a monetary settlement with the insurance carrier.